(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium

C29H29F6N2O3Y- — CID 159717770

IUPAC(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium
SMILESCC(=O)C(CCC(F)(F)F)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cc(C)[c-]c(C)c2CC1=O.[Y]
InChIInChI=1S/C29H29F6N2O3.Y/c1-16-13-17(2)22-15-24(39)26(36-25(23(22)14-16)19-7-5-4-6-8-19)37-27(40)21(10-12-29(33,34)35)20(18(3)38)9-11-28(30,31)32;/h4-8,14,20-21,26H,9-12,15H2,1-3H3,(H,37,40);/q-1;/t20?,21-,26-;/m1./s1
InChIKeyGFJUJVBWQREJFX-MXZMCTFZSA-N
MW656.46 g/mol
LogP6.01
Rot. Bonds9

About (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium

(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium (PubChem CID 159717770) has the molecular formula C29H29F6N2O3Y- and a molecular weight of 656.46 g/mol. Its IUPAC name is (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium.

Molecular Properties

Compound Name(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium
PubChem CID159717770
Molecular FormulaC29H29F6N2O3Y-
Molecular Weight656.46 g/mol
Exact Mass656.11
IUPAC Name(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium
SMILESCC(=O)C(CCC(F)(F)F)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cc(C)[c-]c(C)c2CC1=O.[Y]
InChIInChI=1S/C29H29F6N2O3.Y/c1-16-13-17(2)22-15-24(39)26(36-25(23(22)14-16)19-7-5-4-6-8-19)37-27(40)21(10-12-29(33,34)35)20(18(3)38)9-11-28(30,31)32;/h4-8,14,20-21,26H,9-12,15H2,1-3H3,(H,37,40);/q-1;/t20?,21-,26-;/m1./s1
InChIKeyGFJUJVBWQREJFX-MXZMCTFZSA-N
XLogP6.01
TPSA75.60 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds9
Heavy Atoms41
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500656.46
LogP ≤ 56.01
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'}

Analyze (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium?
The IUPAC name of (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium (CID 159717770) is (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium.
What is the SMILES notation for (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium?
The canonical SMILES for (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium is CC(=O)C(CCC(F)(F)F)[C@@H](CCC(F)(F)F)C(=O)N[C@H]1N=C(c2ccccc2)c2cc(C)[c-]c(C)c2CC1=O.[Y].
What is the InChIKey of (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium?
The InChIKey is GFJUJVBWQREJFX-MXZMCTFZSA-N. The full InChI is InChI=1S/C29H29F6N2O3.Y/c1-16-13-17(2)22-15-24(39)26(36-25(23(22)14-16)19-7-5-4-6-8-19)37-27(40)21(10-12-29(33,34)35)20(18(3)38)9-11-28(30,31)32;/h4-8,14,20-21,26H,9-12,15H2,1-3H3,(H,37,40);/q-1;/t20?,21-,26-;/m1./s1.
What are the key properties of (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium?
(2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium has a molecular weight of 656.46 g/mol, XLogP of 6.01, 9 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for (2R,3S)-3-acetyl-N-[(3S)-6,8-dimethyl-4-oxo-1-phenyl-5,7-dihydro-3H-2-benzazepin-7-id-3-yl]-6,6,6-trifluoro-2-(3,3,3-trifluoropropyl)hexanamide;yttrium is sourced from PubChem (CID 159717770), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).